Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians

被引:18
|
作者
Biswas, Arijit [1 ]
Ranjan, Ravi [1 ]
Meena, Arvind [1 ]
Akhter, Suhail [1 ]
Sharma, Vinita [1 ]
Yadav, Birendra Kumar [1 ]
Behari, Madhuri [1 ]
Saxena, Renu [1 ]
机构
[1] All India Inst Med Sci, Dept Hematol, New Delhi 110029, India
关键词
Factor V Leiden mutation; Factor V HR2 Haplotype; Coagulation Inhibitors; Factor VIII levels; Acute phase; Asian-Indians; ACTIVATED PROTEIN-C; FACTOR-V-LEIDEN; ISCHEMIC-STROKE; VENOUS THROMBOEMBOLISM; FACTOR V-R506Q; RESISTANCE; MUTATION; MARKERS; INACTIVATION; THROMBOPHILIA;
D O I
10.1016/j.thromres.2009.02.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Several prothrombotic factors - both hereditary and acquired - are known to cause stroke. Commonly investigated causes are activated protein C resistance, factor V Leiden mutation, factor VIII levels, prothrombin 20210 G-to-A mutation, coagulation inhibitors such as proteins C and S, and anti phospholipid antibodies such as beta(2)-glycoprotein. Objective: The literature on the prevalence of hematological defects pertaining to these variables in the Asian Indian stroke population is limited to a few isolated reports. In the current study we investigate the above-mentioned variables in 120 stroke patients (non-cardioembolic acute-onset stroke) and compare their status with the hematological profile of an equal number of healthy age- and sex-matched controls. Material and Methods: Plasma and blood leukocytes were collected from all patients and controls for performing hematological assays and molecular tests respectively. The mutations were detected using standard polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) procedures. Statistical analysis was done using SPSS version 12.0. Results: Factor V Leiden (prevalence 8.3% in patients) and activated protein C resistance (prevalence 19.6% in patients) both showed a high degree of association (P<0.01) with the disease condition. However, contrary to common expectations, factor V Leiden was observed much less frequently in patients showing activated protein C resistance (10 out of 23; 43.4%) than is commonly observed in the Caucasian population (almost 90%). Post-acute-phase factor VIII levels were also found to be significantly associated with stroke: 125.6 + 21.1% number of profitable positions (NPP) for controls and 136.2 + 28.8% NPP for patients (P = 0.001). Conclusion: factor V mutations, such as factor V Leiden, may be important risk factors for stroke in an Asian Indian population. Activated protein C resistance has a stronger association with stroke than factor V Leiden and may be caused by other factors such as elevated factor VIII levels in the Asian Indian population apart from factor V Leiden itself. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 50 条
  • [31] Prognosis of dolichoectasia in non-cardioembolic transient ischemic attack and minor stroke
    Zhang, Xinmiao
    Jing, Jing
    Zhao, Xingquan
    Liu, Liping
    Meng, Xia
    Wang, Anxin
    Pan, Yuesong
    Wang, David
    Wang, Yilong
    Wang, Yongjun
    NEUROLOGICAL RESEARCH, 2018, 40 (06) : 452 - 458
  • [32] Hypertensive patients with non-cardioembolic ischemic stroke, a therapeutic hope Reply
    Fernandez-Travieso, Julio C.
    REVISTA DE NEUROLOGIA, 2019, 68 (01) : 44 - 45
  • [33] The efficacy and safety of intravenous anticoagulants for non-cardioembolic stroke: the Japan Stroke Data Bank
    Itabashi, Ryo
    Yoshimura, Sohei
    Koga, Masatoshi
    Nakai, Michikazu
    Miyamoto, Yoshihiro
    Matsumoto, Kenichi
    Yagita, Yoshiki
    Inaba, Makoto
    Katayama, Masateru
    Yazawa, Yukako
    Hatano, Takeo
    Yoshida, Yasuhisa
    Wada, Naomichi
    Kamiyama, Kenji
    Ogasawara, Kuniaki
    Toyoda, Kazunori
    Minematsu, Kazuo
    CEREBROVASCULAR DISEASES, 2024, 53 : 62 - 62
  • [34] Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRI
    De Marchis, Gian Marco
    Toebak, Anna
    Dittrich, Tolga
    Vlachos, Dimitrios
    Wang, Angela
    Smith, Eric E.
    Mundl, Hardi
    Colorado, Pablo
    Shoamanesh, Ashkan
    Hart, Robert G.
    EUROPEAN STROKE JOURNAL, 2025,
  • [35] The ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke
    Joaquín Serena
    Tomás Segura
    Jaume Roquer
    María García-Gil
    José Castillo
    BMC Neurology, 15
  • [36] The ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke
    Serena, Joaquin
    Segura, Tomas
    Roquer, Jaume
    Garcia-Gil, Maria
    Castillo, Jose
    BMC NEUROLOGY, 2015, 15
  • [37] Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
    Krishnan, Kailash
    Law, Zhe Kang
    Minhas, Jatinder S.
    Bath, Philip M.
    Robinson, Thompson G.
    Sprigg, Nikola
    Mavilakandy, Akash
    England, Timothy J.
    Eveson, David
    Mistri, Amit
    Dawson, Jesse
    Appleton, Jason P.
    CLINICAL MEDICINE, 2022, 22 (05) : 449 - 454
  • [38] Risk factors of metabolic syndrome in young adult Asian Indians
    Shah, T
    Jonnalagadda, SS
    Kicklighter, JR
    Diwan, S
    Hopkins, BL
    FASEB JOURNAL, 2004, 18 (04): : A147 - A147
  • [39] Heart rate variability and delirium in acute non-cardioembolic stroke: a prospective, cross-sectional, cohort study
    Eleonora Rollo
    Jessica Marotta
    Antonio Callea
    Valerio Brunetti
    Catello Vollono
    Irene Scala
    Claudio Imperatori
    Giovanni Frisullo
    Aldobrando Broccolini
    Giacomo Della Marca
    Neurological Sciences, 2022, 43 : 2423 - 2431
  • [40] Homocystine Levels, Polymorphisms and the Risk of Ischemic Stroke in Young Asian Indians
    Biswas, Arijit
    Ranjan, Ravi
    Meena, Arvind
    Akhter, Mohammad Suhail
    Yadav, Birendra Kumar
    Munisamy, Murali
    Subbiah, Vivekanandhan
    Behari, Madhuri
    Saxena, Renu
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2009, 18 (02): : 103 - 110